Great Valley Advisor Group Inc. Boosts Stock Position in iShares Biotechnology ETF (NASDAQ:IBB)

Great Valley Advisor Group Inc. lifted its position in iShares Biotechnology ETF (NASDAQ:IBB) by 14.1% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 2,786 shares of the financial services provider’s stock after purchasing an additional 344 shares during the quarter. Great Valley Advisor Group Inc.’s holdings in iShares Biotechnology ETF were worth $378,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently modified their holdings of IBB. Bank of New York Mellon Corp boosted its holdings in shares of iShares Biotechnology ETF by 3.5% in the 3rd quarter. Bank of New York Mellon Corp now owns 21,146 shares of the financial services provider’s stock worth $2,586,000 after purchasing an additional 716 shares in the last quarter. Macroview Investment Management LLC lifted its stake in shares of iShares Biotechnology ETF by 5,340.0% in the 3rd quarter. Macroview Investment Management LLC now owns 544 shares of the financial services provider’s stock valued at $67,000 after acquiring an additional 534 shares during the last quarter. Park Avenue Securities LLC bought a new stake in shares of iShares Biotechnology ETF in the 3rd quarter valued at about $238,000. CENTRAL TRUST Co lifted its stake in shares of iShares Biotechnology ETF by 1.2% in the 3rd quarter. CENTRAL TRUST Co now owns 14,838 shares of the financial services provider’s stock valued at $1,815,000 after acquiring an additional 174 shares during the last quarter. Finally, Whittier Trust Co. lifted its stake in shares of iShares Biotechnology ETF by 26.4% in the 3rd quarter. Whittier Trust Co. now owns 6,471 shares of the financial services provider’s stock valued at $791,000 after acquiring an additional 1,350 shares during the last quarter. 62.45% of the stock is currently owned by hedge funds and other institutional investors.

iShares Biotechnology ETF Price Performance

NASDAQ IBB opened at $132.96 on Monday. iShares Biotechnology ETF has a 1-year low of $111.83 and a 1-year high of $141.16. The stock has a 50-day moving average of $133.61 and a 200-day moving average of $130.12.

iShares Biotechnology ETF Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Wednesday, March 27th. Stockholders of record on Friday, March 22nd were paid a $0.126 dividend. This represents a $0.50 dividend on an annualized basis and a dividend yield of 0.38%. The ex-dividend date of this dividend was Thursday, March 21st.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.